Congress Bought Hemp THC One More Month. It Didn't Buy Anyone Safety.

Walk into most gas stations in Phoenix or Grand Rapids right now and the cooler by the register has a six-pack of seltzer next to the energy drinks, 5mg or 10mg THC per can, sold as “hemp,” no age-gated dispensary required. That product is legal today for one reason: a one-month clock President Trump just reset.

On September 2, Trump signed a government funding bill that pushed the deadline for federal restrictions on hemp-derived THC products from November 12 to December 11, 2026 — a 30-day patch, not a fix, for a multi-billion-dollar hemp-THC marketplace that Foley Hoag’s cannabis law group says employs upwards of 350,000 people who now have exactly one more month of certainty than they had in August.

The federal government has spent a year selling “modernization” on cannabis while building none of the infrastructure that would make it safe.

That’s the throughline, and it isn’t limited to hemp. In California — a state with one of the country’s most mature regulatory frameworks — cannabis control director Clint Kellum said this month that the DEA “hasn’t shown any sort of interest” in giving states any guidance on implementing rescheduling — moving marijuana to a less-restricted federal drug category, which is supposed to loosen research rules and banking access. States are the ones expected to build the actual rules around that shift, and the DEA won’t explain to them what those rules should be, even as it turns around and asks California for more detail on its own medical program.

Meanwhile Michigan — again, a regulated state, with testing requirements the hemp-drink aisle doesn’t have — pulled 786 units of marijuana concentrate off shelves this month after lab testing turned up a banned chemical the state’s own Cannabis Regulatory Agency won’t name publicly. If the best-resourced state programs can’t catch contamination before it reaches a dispensary counter, the hemp-THC drink with no dispensary, no state license, and no mandated lab panel at all is not somehow safer. It’s just less watched.

None of this is a coincidence of timing. It’s what “legalization-adjacent” looks like without the guardrails, and it’s a pattern we keep tracking in our policy and funding coverage: rescheduling momentum with no DEA guidance behind it, a hemp reprieve with no potency standard behind it, a state recall system that still can’t tell the public what it found. Every one of these products, hemp or dispensary, falls under the same cannabinoids umbrella — the industry has just built two separate risk profiles under one label.

If you’re using a gas-station gummy or seltzer to take the edge off cravings, sleep, or a comedown from something else, you deserve to know what’s actually in it — and right now, in a lot of cases, nobody regulating it does either.

This week’s move for providers and case managers: add a specific line to intake — not “cannabis use,” but “hemp-derived THC products: drinks, gummies, vapes bought at a gas station or smoke shop.” Patients routinely don’t code a Delta-9 seltzer — Delta-9 being the main compound that gets you high in both marijuana and hemp — as “cannabis” when asked the standard question, because it wasn’t sold as cannabis. That blind spot is now federally sanctioned through at least December 11.

Congress bought the hemp industry another month. It didn’t buy anyone a potency standard, a testing mandate, or a straight answer from the DEA. Until one of those exists, the only oversight on that gas-station cooler is whoever decides to drink from it.